Randy Lieber - Cellcyte Genetics Insider

CCYG -- USA Stock  

USD 0.0006  0.00  0.00%

Principal Accounting Officer, Director

Mr. Randy A. Lieber is Principal Accounting Officer and Director of CellCyte Genetics Corporationrationration. He is a senior financial professional with more than 29 years of experience working with both public and private companies. He is also the Chief Financial Officer of Blink Interactive, Inc., a user experience, research and design firm based in Seattle, WA. Mr. Lieber started his professional career at Coopers LybrandPricewaterhouseCoopers where he spent 14 years working with a wide range of companies including software, semiconductor, biotechnology and Internet companies. While at PwC, he was involved in more than 10 initial and followon public offerings, financial reporting to the Securities and Exchange Commission, and provided buyside consulting and due diligence on mergers and acquisitions. Subsequent to his tenure at PwC, Mr. Lieber was the Director of Finance at a 500 million international public company, Chief Financial Officer of an internet startup company, and more recently, as the Chief Financial Officer of Ascentium Corporationrationration, a technology and marketing consulting firm. He joined Ascentium shortly after it was founded in 2001 and was instrumental in helping it to grow to annual revenues of 75 Million with offices in seven cities, including London. He was responsible for all finance, accounting, human resources, and facilities
Age: 55  Director Since 2008  CPA    
425-519-3755  http://www.cellcyte.com
Lieber has BS degree in accounting from Central Washington University and became a CPA in Alaska in 1987 and in California in 1996. He is on the Board of Directors of the Greater Seattle USBC Youth Bowling Association and the Greater Seattle USBC Association.

Management Efficiency

The company has return on total asset (ROA) of (415.29) % which means that it has lost $415.29 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (22.9) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

CellCyte Genetics Corporation, a development stage biotechnology company, engages in the research and development of medical devices for cell expansion and maintenance in the United States. The company was founded in 2005 and is based in Bellevue, Washington. Cellcyte Genetics is traded on BATS Exchange in USA.Cellcyte Genetics [CCYG] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Cellcyte Genetics Management Team

John Fluke, Chairman
Randy Lieber, Director, CPA
Douglas Cerretti, President, Ph.D

Stock Performance Indicators

Did you try this?

Run Coins and Tokens Correlation Now

Coins and Tokens Correlation

Utilize digital token correlation table to build portfolio of cryptocurrencies across multiple exchanges
All  Next Launch Coins and Tokens Correlation

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Cellcyte Genetics and Ecopetrol S A. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.